Case Name (Date)

Thompson et al. v. Chattem, Inc.
23-cv-3073, N.D. Cal.
(June 2023)


Product/Service

Cortizone-10


Allegations

Falsely marketing products with 1% hydrocortisone as “maximum strength” when other products contain higher concentrations of the ingredient


Status

Dismissed



Class-Action Tracker

ACT Dry Mouth Lozenges

Class Action

ACT Dry Mouth Lozenges

Allegations: Failing to disclose that the product is detrimental to oral health due to having a pH level that is below the pH level of tooth enamel and root dentin


The Latest

Filters

Aspercreme

Ad Alert

Aspercreme

TINA.org investigates after doctor challenges pain reliever’s “clinically proven” labeling claim on Twitter.

Nasacort

Ad Alert

Nasacort

Makers of nasal allergy spray told to cease consumer preference claims.